GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 702 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $632,000 | -69.5% | 16,448 | -61.5% | 0.00% | -75.0% |
| Q2 2014 | $2,072,000 | -48.6% | 42,773 | -43.3% | 0.00% | -42.9% |
| Q1 2014 | $4,034,000 | +251.7% | 75,497 | +239.9% | 0.01% | +250.0% |
| Q4 2013 | $1,147,000 | -83.0% | 22,214 | -83.5% | 0.00% | -83.3% |
| Q3 2013 | $6,740,000 | -34.5% | 134,349 | -34.8% | 0.01% | -36.8% |
| Q2 2013 | $10,290,000 | – | 205,918 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 5,993,336 | $264,217,000 | 32.64% |
| Black Creek Investment Management Inc. | 10,373,943 | $457,491,000 | 12.20% |
| KAHN BROTHERS GROUP INC | 1,438,569 | $63,440,893,000 | 8.71% |
| EQUITY INVESTMENT CORP | 2,932,078 | $129,305,000 | 4.68% |
| JET CAPITAL INVESTORS L P | 400,000 | $17,640,000 | 4.67% |
| Eversept Partners, LP | 1,503,700 | $66,313,170 | 4.24% |
| NKCFO LLC | 269,500 | $11,885,000 | 3.82% |
| Camber Capital Management LP | 2,500,000 | $110,250,000 | 3.79% |
| CLIFFORD CAPITAL PARTNERS LLC | 113,866 | $5,021,000 | 3.75% |
| Robinson Value Management, Ltd. | 97,677 | $4,308,000 | 3.54% |